PER 1.35% 7.5¢ percheron therapeutics limited

For General Information, page-3011

  1. 3,556 Posts.
    lightbulb Created with Sketch. 771
    It's almost impossible from here for any company to find more / new applications for ATL1102...including broader inflammation

    GT has been on it for years and it's going to hard to beat years of thinking especially when he is expert in patents...

    Which is good as any Pharmas wants to use they come to us ....

    Would love to get some update on trials .I guess Q will reveal and it has to be a smashing one..

    If lucky end of Sep / Oct start..which is 3-4 weeks away..
    GL..IMO
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.